Recombinant Human C4BPa Protein，His

C4BPa, or complement component 4 binding protein alpha, is a crucial regulatory protein involved in the complement system, an integral part of the immune response. It exists as a hetero-oligomeric complex that plays a significant role in modulating inflammation and immune responses by binding to and inactivating complement proteins, particularly C4b and C3b. The dysregulation of C4BPa has been associated with various pathological conditions, including autoimmune diseases, infections, and cardiovascular diseases, highlighting its potential as a therapeutic target. Recent studies have focused on the recombinant expression of C4BPa to better understand its structural and functional properties. Researchers aim to characterize the protein’s binding interactions and regulatory mechanisms, providing insights into its role in immune regulation. Understanding C4BPa's structure-function relationship could pave the way for novel therapeutic interventions, including the development of drugs that mimic or inhibit its activity to enhance immune responses in disease contexts. Additionally, the recombinant version of C4BPa offers a tool for further investigation into the complement system's dynamics, with the potential for application in diagnostic and therapeutic settings. Researchers are also exploring the implications of C4BPa in various diseases, making it a focal point for studies aimed at unraveling the complexities of immune regulation and the development of targeted therapies. Overall, ongoing research into C4BPa not only contributes to our understanding of complement regulation but also holds promise for advancing immune-related therapies and improving patient outcomes in a range of diseases.